Lineage, Inc. Common Stock (LINE)vsRegency Centers Corporation (REG)
LINE
Lineage, Inc. Common Stock
$40.39
-1.32%
REAL ESTATE · Cap: $11.14B
REG
Regency Centers Corporation
$78.67
+1.36%
REAL ESTATE · Cap: $15.01B
Smart Verdict
WallStSmart Research — data-driven comparison
Lineage, Inc. Common Stock generates 225% more annual revenue ($5.36B vs $1.65B). REG leads profitability with a 33.1% profit margin vs -2.7%. REG earns a higher WallStSmart Score of 63/100 (C+).
LINE
Avoid34
out of 100
Grade: F
REG
Buy63
out of 100
Grade: C+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for LINE.
Margin of Safety
+44.0%
Fair Value
$136.47
Current Price
$78.67
$57.80 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Keeps 33 of every $100 in revenue as profit
Strong operational efficiency at 40.7%
Reasonable price relative to book value
Areas to Watch
0.4% revenue growth
0.0% earnings growth
Operating margin of 3.3%
Elevated debt levels
Moderate valuation
Expensive relative to growth rate
Distress zone — elevated risk
Comparative Analysis Report
WallStSmart ResearchBull Case : LINE
The strongest argument for LINE centers on Price/Book.
Bull Case : REG
The strongest argument for REG centers on Profit Margin, Operating Margin, Price/Book. Profitability is solid with margins at 33.1% and operating margin at 40.7%.
Bear Case : LINE
The primary concerns for LINE are Revenue Growth, EPS Growth, Operating Margin.
Bear Case : REG
The primary concerns for REG are P/E Ratio, PEG Ratio, Altman Z-Score.
Key Dynamics to Monitor
LINE profiles as a turnaround stock while REG is a mature play — different risk/reward profiles.
REG is growing revenue faster at 10.0% — sustainability is the question.
REG generates stronger free cash flow (48M), providing more financial flexibility.
Monitor REIT - INDUSTRIAL industry trends, competitive dynamics, and regulatory changes.
Bottom Line
REG scores higher overall (63/100 vs 34/100), backed by strong 33.1% margins. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Lineage, Inc. Common Stock
REAL ESTATE · REIT - INDUSTRIAL · USA
Lineage, Inc. (Ticker: LINE) is an innovative biotechnology company specializing in regenerative medicine, with a focus on developing state-of-the-art cell therapies for conditions such as ocular diseases, spinal cord injuries, and various cancers. Leveraging its proprietary technologies and strong strategic partnerships, Lineage aims to revolutionize patient care with pioneering therapeutic solutions. The company’s dedication to advancing its diverse product pipeline and accelerating clinical trials positions it as a compelling investment prospect for institutional investors looking to engage at the cutting edge of healthcare advancements.
Visit Website →Regency Centers Corporation
REAL ESTATE · REIT - RETAIL · USA
Regency Centers Corporation is a real estate investment trust based in Jacksonville, Florida and is one of the largest operators of shopping centers with grocery stores as anchor tenants.
Compare with Other REIT - INDUSTRIAL Stocks
Want to dig deeper into these stocks?